renal medullary carcinoma

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

Active, not recruiting
  • Malignant Rhabdoid Tumors (MRT)
  • +10 more
  • San Francisco, California
  • +31 more
Jan 17, 2023

Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

Temporarily not available
  • Epithelioid Sarcoma (Ex-US Only)
  • +19 more
  • (no location specified)
Oct 17, 2022

All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,

Active, not recruiting
  • All Malignancies
  • +11 more
  • Encinitas, California
  • +9 more
May 20, 2022

Carcinomas, Renal Medullary Carcinoma Trial in Houston (Nivolumab, Relatlimab)

Not yet recruiting
  • Carcinomas
  • Renal Medullary Carcinoma
  • Houston, Texas
    MD Anderson Cancer Center
Apr 20, 2022

Adult Acute Myeloid Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia

Completed
  • Adult Acute Myeloid Leukemia in Remission
  • +29 more
  • Fludarabine Phosphate
  • +5 more
  • Tucson, Arizona
  • +9 more
Dec 18, 2019